Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dalteparin Sodium Injection

Approval Number

国药准字H20204000

Company河北常山生化药业股份有限公司

Registration Date

October 23, 2023

Previous Approval Numbers

国药准字H20143110

Drug Information

Generic Name

达肝素钠注射液

Dosage Form

注射剂

Strength

0.3ml:7500AXaIU

Drug Type

化学药品

Registration Date

October 23, 2023

Company Information

Applicant Company

Company Name河北常山生化药业股份有限公司

Company Address

中国（河北）自由贸易试验区正定片区正定县高新技术产业开发区南区梦龙街71号

Manufacturing Company

Company Name河北常山生化药业股份有限公司

Company Address

中国（河北）自由贸易试验区正定片区正定县高新技术产业开发区南区梦龙街71号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy